Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)-Reference-Cited by-同舟云学术

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Published:2011-12-25 Issue:3 Volume:132 Page:1049-1062
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Esserman Laura J., ,Berry Donald A.,Cheang Maggie C. U.,Yau Christina,Perou Charles M.,Carey Lisa,DeMichele Angela,Gray Joe W.,Conway-Dorsey Kathleen,Lenburg Marc E.,Buxton Meredith B.,Davis Sarah E.,van’t Veer Laura J.,Hudis Clifford,Chin Koei,Wolf Denise,Krontiras Helen,Montgomery Leslie,Tripathy Debu,Lehman Constance,Liu Minetta C.,Olopade Olufunmilayo I.,Rugo Hope S.,Carpenter John T.,Livasy Chad,Dressler Lynn,Chhieng David,Singh Baljit,Mies Carolyn,Rabban Joseph,Chen Yunni-Yi,Giri Dilip,Au Alfred,Hylton Nola

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1895-2

Reference45 articles.

1. van de Vijver MJ, He YD, Van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009

2. Paik S, Tang G, Shak S et al (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726–3734

3. Cheang MC, Chia Sk, Boduc D et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736–750

4. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874

5. Rouzier R, Perou CM, Symmans WF et al (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678–5685

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy;Journal of Oncology Pharmacy Practice;2024-07-26

2. Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence;Science Advances;2024-04-05

3. Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study;Turkish Journal of Surgery;2024-03-01

4. Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients;Heliyon;2024-03

5. Discovery of a proliferation essential gene signature and actin‐like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple‐positive breast cancer;Cancer;2024-02-15